OrbiMed’s Perspective Therapeutics CATX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-492,670	Closed	-$4.91M	–	113
2024 Q2	$4.91M	Sell	492,670 -157,910	-24%	-$1.57M	0.1%	86
2024 Q1	$7.74M	Buy	+650,580	New	+$7.74M	0.14%	88